tretinoin and Morphine-Dependence

tretinoin has been researched along with Morphine-Dependence* in 1 studies

Other Studies

1 other study(ies) available for tretinoin and Morphine-Dependence

ArticleYear
The role of reactive oxygen species in morphine addiction of SH-SY5Y cells.
    Life sciences, 2015, Mar-01, Volume: 124

    The alteration of ROS level is frequently observed in the course of morphine addiction, and ROS is proverbially involved in this process. This study aims to explore the relationship among morphine addiction, reactive oxygen species (ROS) and expression of μ-opioid receptor (MOR) in differentiated SH-SY5Y cells.. SH-SY5Y cells were induced to differentiation by treatment with retinoic acid (RA); the activity of lactate dehydrogenase (LDH) and the nitro blue tetrazolium (NBT) reduction were assessed by spectrophotometry. Intracellular reactive oxygen species (ROS) was measured with the 2,7-dichlorofluorescin diacetate (DCFH-DA) assay. Cellular cAMP was determined by using a competitive protein binding kit. The mRNA expression of μ-opioid receptor (MOR) was evaluated by qRT-PCR.. Morphine-induced ROS are generated in a concentration- and time-dependent manner and inhibited by naloxone. Exogenous oxidants increase the level of ROS and aggravate morphine addiction, while the exogenous antioxidants efficiently reverse these effects. Morphine decreases the mRNA level of MOR in a concentration-dependent manner. And the mRNA level of MOR is remarkably reduced in the presence of exogenous oxidants and effectively promoted by antioxidants.. This study indicates that ROS can affect morphine addiction through involving MOR. Treatment with ROS scavenging can serve as a medical therapy for morphine addiction.

    Topics: Analgesics, Opioid; Antioxidants; Cell Differentiation; Cell Line, Tumor; Cyclic AMP; Dose-Response Relationship, Drug; Humans; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Neuroblastoma; Reactive Oxygen Species; Receptors, Opioid, mu; RNA, Messenger; Time Factors; Tretinoin

2015